Substituted pyrrolidine amides, the production thereof, and the use thereof as medications
申请人:Boehringer Ingelheim International GmbH
公开号:US08309542B2
公开(公告)日:2012-11-13
The object of the present invention is novel substituted pyrrolidine amides of the general formula (I) in which D, L. E, G, J, M, L1, L2, R4, and R5 are defined as in the specification, the tautomers, enantiomers, diastereomers, mixtures, and salts thereof, particularly physiologically tolerated salts with inorganic or organic acids or bases having valuable properties.
本发明的对象是一种新的取代吡咯烷酰胺,其通式为(I),其中D、L、E、G、J、M、L1、L2、R4和R5如规范中所定义,其互变异构体、对映异构体、顺反异构体、混合物和盐,特别是与无机或有机酸或碱物理上耐受的盐具有有价值的性质。